Elevance Health Inc (ELV · NYSE)

ELV · MARKET VIEW

Market view · as of Jun 2, 2026

Revenue (TTM)
$200.42B
+2.6% YoY
Gross margin
25.9%
EPS (latest q)
$12.58
vs $10.81 est · beat
52-wk position
100.0%
0.0% vs 52w high · +8.0% 1mo

Price (last ~year)

Elevance Health shares reached $402.66, reflecting a 41.4% gain over the last three months alongside a first-quarter 2026 report of $50.18 billion in revenue and $12.58 in earnings per share. The company maintains a market capitalization of $87.44 billion with a P/E ratio of 17.07 and $31.84 billion in total debt. Truist Securities recently raised its price target for the stock to $450.00.

Valuation

Market cap
$87.44B
P/E
17.07
PEG
1.439
P/B
1.945
P/S
0.426
Beta
0.671
Analyst target
$404.05

Quality & returns

Gross margin
25.9%
Operating margin
5.3%
Profit margin
2.6%
ROE
12.1%
ROA
4.0%

Price movement

Last
$402.66
1-month
+8.0%
3-month
+41.4%
RSI (14)
64
vs SMA200
+20.9%
52-wk position
100.0% 0.0% vs high

Quarterly trajectory

Revenue by quarter (oldest → newest)

QuarterRevenueOp incomeNet incomeEBITDA
2026-03-31$50.18B$2.66B$1.76B$2.77B
2025-12-31$49.75B$581.0M$547.0M$987.0M
2025-09-30$50.71B$1.76B$1.19B$2.14B
2025-06-30$49.78B$2.63B$1.74B$3.01B

Recent news

Sources this view read

  • fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
  • filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
  • earnings Reported earnings history (Alpha Vantage EARNINGS)
  • prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)

Other snapshots